Registered Trademark - sildenafil citrate, a phosphodiesterase-5 inhibitor first clinically tested for the treatment of angina due to its blood vessel expanding properties. In clinical trials, erections resulted as an unforseen side effect and seeing the potential profit, it was later FDA approved and marketed for this purpose.
